Champions Oncology (CSBR) EBIT Margin (2010 - 2026)
Champions Oncology's (CSBR) quarterly EBIT Margin came in at 2.69% in Q3 2026, up 108.0% year-over-year from 1.29% in Q3 2025, and up 28.83% on a QoQ basis from 3.77% in Q2 2026.
Powered by 
Analysis
Champions Oncology (CSBR) EBIT Margin (2010 - 2026) Analysis & Trends
Champions Oncology (CSBR) has 17 years of EBIT Margin data on file, last reported at 2.69% in Q3 2026.
- On a quarterly basis, EBIT Margin rose 108.0% year-over-year to 2.69% in Q3 2026; TTM through Jul 2026 was 1.68%, a 643.0% decrease from a year earlier, with the FY2026 full-year figure at 1.92%, down 991.0% from the prior year.
- EBIT Margin for Q3 2026 stood at 2.69%, up from 3.77% in the prior quarter.
- Across five years, EBIT Margin topped out at 26.4% in Q1 2025 and bottomed at 21.44% in Q1 2024.
- Historically, EBIT Margin has averaged 4.36% across 5 years, with a median of 2.42% in 2022.
- The widest annual swing landed in 2025, when EBIT Margin soared 4785 bps; it then slumped 2807 bps in 2026.
- Year by year, EBIT Margin stood at 0.05% in 2022, then slumped by 34564 bps to 16.89% in 2023, then surged by 132 bps to 5.43% in 2024, then tumbled by 77 bps to 1.23% in 2025, then sank by 318 bps to 2.69% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 2.69% in Q3 2026, 3.77% in Q2 2026, and 1.67% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 20.76% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 6.68% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 11.94% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.18% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -290.47% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -218,381.69% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -15,327.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -2.69% |
| Apr 30, 2026 | -3.77% |
| Jan 31, 2026 | -1.67% |
| Oct 31, 2025 | 1.23% |
| Jul 31, 2025 | -3.77% |
| Apr 30, 2025 | -16.24% |
| Jan 31, 2025 | 26.40% |
| Oct 31, 2024 | 5.43% |
| Jul 31, 2024 | 9.45% |
| Apr 30, 2024 | -1.94% |
| Jan 31, 2024 | -21.44% |
| Oct 31, 2023 | -16.89% |
| Jul 31, 2023 | -20.32% |
| Apr 30, 2023 | -19.29% |
| Jan 31, 2023 | -19.24% |
| Oct 31, 2022 | 0.05% |
| Jul 31, 2022 | -2.07% |
| Apr 30, 2022 | -2.42% |
| Jan 31, 2022 | 6.29% |
| Oct 31, 2021 | 2.23% |